Today's Review on Active Stocks -- Research on Ashford Hospitality Trust, Dejour Energy, North American Palladium, and Gilead Sciences

LONDON, April 10, 2014 /PRNewswire/ --

The trading session on Wednesday, April 9, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,437.18, up 1.11%, and the NASDAQ Composite closed at 4,183.90, up 1.72%. The S&P 500 finished the session 1.09% higher at 1,872.18. The session saw a positive impact from Information Technology, Health Care and Materials sectors along with a drag from Utilities and Telecommunication Services sectors. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Ashford Hospitality Trust Inc. (NYSE: AHT), Dejour Energy Inc. (NYSE: DEJ), North American Palladium Ltd (NYSE: PAL) and Gilead Sciences Inc. (NASDAQ: GILD). Free technical research on AHT, DEJ, PAL and GILD can be downloaded upon signing up at:

http://www.investor-edge.com/1026-register

On Wednesday, Ashford Hospitality Trust Inc.'s shares recorded heavy trading as a total of 9.04 million shares changed hands, as compared with its three-month average volume of 0.76 million shares. The stock traded at an intraday trading range of $10.41 and $10.63, before closing the day at $10.58, down 5.54%. The stock has have fallen by 4.60% in the last one month, while the stock has rallied 27.16% in the previous three months and 27.78% on YTD basis. The S&P 500 Financials Sector Index mapped a loss of 0.10% in the previous three months, while the S&P 500 gained 1.85% during the same period. The stock is trading above its 50-day and 200-day moving averages of $10.49 and $8.79, respectively. On the same day, the company announced that it has priced its follow-on public offering of 7,500,000 shares of common stock at $10.70 per share. Sign up today to read free research on AHT at:

http://www.investor-edge.com/1026-AHT-10Apr2014.pdf

Dejour Energy Inc.'s stock recorded heavy trading as a total of 7.77 million shares changed hands, against its three-month average volume of 1.75 million shares. On Wednesday, the stock finished the day at $0.27, up 11.02% and at an intraday range of $0.23 and $0.29, hitting a new 52-week high of $0.29. Dejour Energy Inc.'s shares have surged 92.46% in the last one month, 67.72% in the previous three trading sessions, and 126.50% on YTD basis. The S&P 500 Energy Sector Index mapped a gain of 2.95% in the last one month, while the NASDAQ Composite Index declined 3.51% during the same period. The stock is trading above its 50-day and 200-day moving averages of $0.19 and $0.18, respectively. Additionally, the company's shares have an RSI of 58.56. Sign up today to read free research on DEJ at:

http://www.investor-edge.com/1026-DEJ-10Apr2014.pdf

Shares in North American Palladium Ltd saw heavy trading as a total of 15.66 million shares changed hands, against its three-month average volume of 6.48 million shares. On Wednesday, the stock closed the day at $0.35, down 12.26% with an intraday fluctuation between $0.34 and $0.39. Shares of North American Palladium Ltd have lost 28.52% in the last one month and 47.03% on YTD basis. The S&P 500 Materials Sector Index gained 4.43% in the previous three months, while the NASDAQ Composite Index advanced 0.67% during the same period. The stock is trading below its 50-day and 200-day moving averages of $0.43 and $0.76, respectively. On April 08, 2014, the company announced that, it is pleased to provide an update on the proposed second tranche of its previously announced public offering of 7.5% convertible unsecured subordinated debentures, including an amendment to the terms and expected closing schedule. Sign up today to read free research on PAL at:

http://www.investor-edge.com/1026-PAL-10Apr2014.pdf

Gilead Sciences Inc.'s shares saw heavy trading as a total of 20.67 million shares changed hands on Wednesday, as compared with its three-month average volume of 14.16 million shares. The stock ended the day at $70.65, up 0.91%, after trading at an intraday range of $69.86 and $71.29. Shares in Gilead Sciences Inc. have declined 11.22% in the last one month and 5.93% on YTD basis. The S&P 500 Health Care Sector Index advanced 2.86% in the previous three months, while the S&P 500 gained 1.85% during the same period. The company's shares are trading at a PE ratio of 37.70 and above its 200-day moving average of $68.77. Moreover, the company's shares have an RSI of 35.79. Sign up today to read free research on GILD at:

http://www.investor-edge.com/1026-GILD-10Apr2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED